Haemodialysis-associated amyloidosis
Haemodialysis-associated amyloidosis is a type of amyloidosis that is commonly seen in patients who have been on haemodialysis for a long period of time. This condition is characterized by the accumulation of beta-2 microglobulin in the body's tissues.
Overview[edit | edit source]
Haemodialysis-associated amyloidosis is a complication of long-term haemodialysis, a treatment for kidney failure. During haemodialysis, waste products are removed from the blood. However, beta-2 microglobulin, a protein that is normally filtered out by the kidneys, is not effectively removed. Over time, this protein can build up in the blood and deposit in tissues, leading to amyloidosis.
Symptoms[edit | edit source]
The symptoms of haemodialysis-associated amyloidosis can vary, but often include joint pain, carpal tunnel syndrome, and bone cysts. In severe cases, it can lead to fractures and joint destruction.
Diagnosis[edit | edit source]
The diagnosis of haemodialysis-associated amyloidosis is typically made based on the patient's symptoms and history of long-term haemodialysis. Imaging tests, such as MRI or CT scan, may be used to detect deposits of beta-2 microglobulin in the tissues. In some cases, a biopsy may be performed to confirm the diagnosis.
Treatment[edit | edit source]
The treatment for haemodialysis-associated amyloidosis primarily involves managing the symptoms. This may include pain management, physical therapy, and in some cases, surgery to remove large deposits of beta-2 microglobulin. In addition, efforts are made to improve the efficiency of haemodialysis to reduce the accumulation of beta-2 microglobulin in the blood.
Prevention[edit | edit source]
The best way to prevent haemodialysis-associated amyloidosis is to prevent kidney failure. This can be achieved through a healthy lifestyle, including a balanced diet, regular exercise, and avoiding harmful substances such as tobacco and alcohol. In patients already on haemodialysis, the use of high-flux dialysis membranes can help to remove more beta-2 microglobulin from the blood, potentially reducing the risk of amyloidosis.
See also[edit | edit source]
| Haemodialysis-associated amyloidosis Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
